Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

medCPU Closes $8 Million Financing, Continues to Reinforce Leadership Position in Clinical Decision Support Market

NEW YORK, N.Y., July 14, 2015 – medCPU, Inc., a leader in enterprise clinical decision support solutions, announced today that it closed an $8 million financing round, consisting of $5 million series B-2 equity and $3 million in debt financing. The equity round was led by Merck Global Health Innovation Fund and New Richmond Ventures, and debt financing was provided by Silicon Valley Bank. This additional funding will enable medCPU to continue to assert its leadership position in the dynamic clinical decision support marketplace.

“We are driven by the confidence of our financial partners to further achieve our vision of changing the face of clinical decision support as it is known today,” said Sonia Ben-Yehuda, President and Co-Founder of medCPU, Inc. “In the past, the adoption of decision support has been stifled by outdated technologies that do not meet the needs of today’s clinicians. Unlike older, unreliable technologies that cause alert fatigue among clinicians, our solution delivers highly accurate and reliable decision support to clinicians at the point-of-care in real-time without disrupting their workflow.”

In a fast-paced environment where every detail is critical to a patient’s quality of care, real-time clinical decision support is a crucial component of a clinician’s workflow. The medCPU Advisor™, medCPU’s enterprise platform technology, acquires and processes both structured and unstructured data immediately as it is entered into a clinician’s Electronic Medical Record (EMR) system. The technology then assesses the data against best practice modules to provide the clinician with a holistic view of their patient and to ultimately provide highly accurate, real-time, reliable prompts at the point-of-care.

“We work with the most innovative companies, and those that have potential to transform the future of healthcare,” commented Michael Hanewich, Managing Director, Head of Life Science and Healthcare Venture Capital Relationships for Silicon Valley Bank. “The medCPU team has the vision and expertise to improve the accuracy and delivery of healthcare as it stands today.”

“Our technology is already being used by over 20,000 clinicians and a number of leading healthcare providers,” added Ms. Ben-Yehuda. ”This financing will help us to continue to grow our market share. We are excited about facilitating the move beyond antiquated, evidence-based reference tools to a new era of clinical decision support.”

medCPU’s solution is simple and seamless to deploy as it does not require integration into an EMR system or complex data connectivity to an interface engine. The medCPU Advisor™ enables healthcare providers to optimize investments already made in their EMRs. Running in the background of an EMR system unseen, the technology reads and captures data without disrupting a clinician’s workflow and only provides notifications when deviation from best practice care consideration occurs.

To meet the needs of different specialized health care organizations, medCPU delivers a wide range of customizable clinical and compliance decision support solutions, including modules for Obstetrics, Spine, Stroke, CHF, COPD, Value Based Purchasing, DRG’s, ICD-10, VTE Prophylaxis, Population Health, and in partnership with ILÚM Health Solutions™ (a subsidiary of Merck & Co., Inc. Kenilworth, NJ) is developing modules for Infectious Diseases such as Sepsis, Pneumonia and Urinary Tract Infection that also enable comprehensive Antimicrobial Stewardship.

About medCPU:
medCPU delivers accurate real-time enterprise decision support software and services through its proprietary Advisor technology. medCPU captures the complete clinical picture from clinicians’ free-text notes, dictations, discharge summaries and structured documentation entered into any Electronic Medical Record (EMR), and analyzes it against a growing library of best-practice content, generating real-time precise prompts for best care consideration. medCPU’s founding multi-disciplinary team has been pioneering new clinical decision support for nearly 20 years, delivering intelligent error reduction software systems to hospitals across the United States. medCPU’s applications include clinical and compliance support solutions. For more information, visit www.medCPU.com.

July 15, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Zoeticx Leverages Crowd Funding to Introduce TruRecord, Medical Prescribing Software That Will Address 2.2 Million Adverse Drug Reactions in U.S.

First EHR-integrated, Precise and Personalized, Mobile Platform to Leverage Advances in DNA Testing for Better Patient Outcomes and Lower Malpractice Payouts

June 29, 2015; San Jose, Calif — Zoeticx, Inc., the developer of medical software that bridges the gap between medical data and quality patient care, today announced a crowd funding campaign for TruRecord, the first subscriber-based, medical prescribing software to leverage advanced DNA testing technology for optimal drug analysis and prevention of adverse drug reactions.

The company is raising funds for a fall launch of TruRecord on medical crowd funding site Medstartr http://www.medstartr.com/projects/662-trurecord

TruRecord improves patient outcomes by reducing the 80,000 annual deaths due to drug adverse reactions, resulting in 289 billion spent annually on malpractice payouts. CDC ranks this as the fourth highest cause of deaths in US. With 30 new medications introduced yearly and 25 percent of patients on multiple medications, the need is growing.  The CDC also ranks this as the fourth highest cause of death in the U.S. after heart disease, cancer and strokes.

TruRecord is designed to foster better patient outcomes by helping to prevent the 100,000 deaths yearly from drugs that are prescribed properly and 80,000 deaths from those which are not, resulting in 289 billion spent annually on malpractice payouts.

Breaking Through Drug Analysis Limitations

Through an intuitive visualization of drug-to-drug interactions, drug-to-allergy interactions, and drug to DNA metabolization, medical professionals can now create what-if scenarios for drug issues, enabling providers to personalize prescriptions. This capability breaks through providers’ drug analysis limitations and the burdensome task of scanning and searching text and tables to identify adverse reaction data which is often complex.

These scenarios can now also be more complete with accurate patient medical information from any facility, including integration from existing hospital EHR’s through Zoeticx’s Patient-Clarity Platform which connects disparate EHR records and enables medical system interoperability.

Mobile Devices, HIPAA Compliance

TruRecord client interfaces are supported on mobile and web interfaces, providing precise, personalized medication prescriptions. TruRecord accesses patient medical records via an on-demand, real time access from EHR / EMR systems. Without data duplication, TruRecord complies with all required secure patient privacy protection outlined by HIPAA.

“We built Zoeticx to help medical systems address interoperability, lower accidental deaths and bridge the gap between medical data and better patient outcomes,” said Thanh Tran, CEO, Zoeticx. “Today our goal is the same, but a shift toward an additional focus—adverse drug reactions. We are ushering in an era where we can leverage the fruits of DNA research to bring more precise and accurate prescriptions to those who rely on them. TruRecord takes the guess work out of drug interactions and patients by delivering security, peace of mind and accuracy.”

About Zoeticx

Zoeticx offers software solutions for the healthcare industry which are dedicated to improving patient outcomes, enhancing the quality of care, containing costs, and simplifying administration. These solutions offer an immediate increase in the quality of care by delivering the right information to the right caregiver at the right time, in a manner that can be easily understood.  Additionally, as the Affordable Care Act continues to roll out, healthcare providers will face new challenges which arise whenever there is a transition from an old system of doing business to a new one. Zoeticx helps solve those challenges, allowing care providers to focus on what is most important, the patient. www.Zoeticx.com For additional information contact Glass Lantern PR at @glasslanternpr.com.

June 25, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Beaufort Memorial Hospital Selects ProVation® Order Sets, powered by UpToDate® Decision Support

MINNEAPOLIS, MN — Oct. 22, 2012— Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Beaufort Memorial Hospital has selected its ProVation® Order Sets, powered by UpToDate® Decision Support, software as the hospital’s electronic order set solution.

ProVation Order Sets is an easily customizable order set authoring and management solution that provides flexible integration into clinical processes to streamline the delivery of standardized care for improved patient safety, outcomes, clinician performance and regulatory compliance. ProVation Order Sets is built upon ProVation Medical’s award-winning, clinician-designed technology platform. A key benefit is continuous updating of clinical content and medical evidence, including direct links to UpToDate, the resource of choice for more than 600,000 users worldwide.

Located in Beaufort, S.C., the 197-bed Beaufort Memorial Hospital is the largest hospital between Savannah, Ga. and Charleston, S.C. and home to more than 150 board certified or board-eligible physicians. Situated on the Atlantic Intracoastal Waterway, the hospital is one of the few hospitals in the country with its own emergency dock. Beaufort Memorial Hospital is a Duke Affiliate in heart and cancer and is Joint Commission-accredited.

“Beaufort Memorial Hospital is dedicated to delivering superior healthcare services to the communities it serves,” said Mike Haldane, Vice President and General Manager, Clinical Documentation, Wolters Kluwer Health Clinical Solutions. “We are pleased that they have selected ProVation Order Sets, powered by UpToDate Decision Support, to further this mission and provide evidence-based medicine at the point of care.”

About ProVation Medical

ProVation® Medical provides procedure documentation and clinical decision support solutions for hospitals and Ambulatory Surgery Centers. ProVation MD, ProVation MultiCaregiver and ProVation EHR software reduce transcription, paper storage and image printing costs and deliver a high Return on Investment (ROI). ProVation® Order Sets, powered by UpToDate Decision Support, put evidence-based healthcare into practice by establishing and maintaining standards of care.

ProVation® Medical is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).

November 20, 2012 I Written By

Datapharm Australia Selects Merge eClinical OS(TM) for Enterprise-Wide Electronic Data Capture

Solution Provides Comprehensive Suite of EDC Tools; Flexibility to Mix and Match Features

CHICAGO, Oct. 4, 2012 (GLOBE NEWSWIRE) — Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Datapharm Australia Pty Ltd. has selected Merge’s eClinical OS™ solution to bring EDC in-house and provide control of electronic case report form (eCRF) creation and mid-study adjustments.

“We’ve seen an increase in the number of our clients’ studies requiring EDC. Previously, we outsourced EDC projects to a third party vendor to handle eCRF setup,” explained Dr. Helen Allars, Managing Director at Datapharm Australia. “We found that we spent more time and resources managing this process and dealing with support issues. This approach also lacked the flexibility and control for mid-study changes.”

In 2010, Datapharm began an extensive EDC vendor evaluation, which included 14 vendors who could offer in-licensing of software for use across an enterprise, also referred to as technology transfer. Datapharm’s evaluation criteria consisted of a comprehensive suite of EDC tools, time to deployment, and overall costs associated with technology transfer.

“eClinical OS provided all the EDC features we needed – such as 21 CFR Part 11 and CDISC compliance, Hybrid/DDE, CRF library, reporting, data upload and exporting, medical coding, and monitoring tools – as well the opportunity to add patient reported outcomes, interactive response, randomization and inventory management if a particular study called for it,” continued Allars. “We were most impressed with how intuitive and flexible the system is, whether we are creating eCRFs or even making mid-study changes.”

“Companies that are bringing our solution in-house are doing so because they recognize that eClinical OS provides a strategic tool in their pursuit to provide more efficient, cost-effective clinical trials services,” said Justin Dearborn, President of Merge Healthcare. “Datapharm has taken the first critical step to yield the greatest efficiencies and financial rewards of using our eClinical technologies to simplify and accelerate the way they perform clinical trials.”

Merge eClinical OS is a unified platform delivering end-to-end study support. Clinical trial capabilities can be mixed and matched to build a solid foundation for each trial environment, and features and services can be added as needed, directly from within the system. As a single, web-based solution, it has the flexibility to support trials in any phase, and captures any type of data, from any source, over any modality. Merge eClinical OS also has the scalability to grow if a trial increases in size, number or complexity.

About Merge Healthcare

Merge is a leading provider of clinical systems and innovations that seek to transform healthcare.  Merge’s enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 20 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit merge.com.

About Datapharm Australia

Datapharm Australia is Australia’s most experienced Full Service Contract Research Organization (CRO), celebrating 25 years in 2012. Services include: clinical trial management, set-up, monitoring, data management, statistical analysis and programming, medical writing, pharmacovigilance and auditing for Phase I to IV studies in over 35 therapeutic areas since 1987. Datapharm aims to provide clients with the best cost-effective, quality outcomes. For more information, visit DatapharmAustralia.com.

November 13, 2012 I Written By

Rochester General Health System Selects ProVation® Order Sets, powered by UpToDate® Decision Support

MINNEAPOLIS, MN — Aug. 21, 2012— Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Rochester General Health System has selected its ProVation® Order Sets, powered by UpToDate® Decision Support, software as its electronic order set solution.

ProVation Order Sets is an easily customizable order set authoring and management solution that provides flexible integration into clinical processes to streamline the delivery of standardized care for improved patient safety, outcomes, clinician performance and regulatory compliance. ProVation Order Sets is built upon ProVation Medical’s award-winning, clinician-designed technology platform. A key benefit is continuous updating of clinical content and medical evidence, including direct links to UpToDate, the resource of choice for more than 600,000 users worldwide.

Located in Rochester, NY, Rochester General Health System is one of the fastest growing health systems in western and central New York State and is the only area health system to be rated by SDI as one of the Top 100 Integrated Health Networks in the U.S. It includes eight clinically integrated affiliates delivering comprehensive healthcare services, including Rochester General Hospital, Newark-Wayne Community Hospital, Hill Haven Assisted Living and Nursing Rehabilitation Center, DeMay Living Center, Rochester General Medical Group, Behavioral Health Network, Independent Living for Seniors, and RGHS Ambulatory Services Division. Rochester General Health System and its affiliates regularly earn national recognition for excellence in a range of clinical specialties.

“Rochester General Health System has a reputation for providing medical excellence,” said Mike Haldane, Vice President and General Manager, Clinical Documentation, Wolters Kluwer Health Clinical Solutions. “We are pleased they have selected ProVation Order Sets, powered by UpToDate Decision Support, to provide its clinicians with point-of-care access to evidence-based order sets.”

About ProVation Medical

ProVation® Medical provides procedure documentation and clinical decision support solutions for hospitals and Ambulatory Surgery Centers. ProVation MD, ProVation MultiCaregiver and ProVation EHR software reduce transcription, paper storage and image printing costs and deliver a high Return on Investment (ROI). ProVation® Order Sets, powered by UpToDate Decision Support, puts evidence-based healthcare into practice by establishing and maintaining standards of care.

ProVation® Medical is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).

September 18, 2012 I Written By

Windsor Health Group Selects MedHOK’s Single Platform for Care, Quality and Compliance for Clinical and Compliance Programs

TAMPA, Fla. – August 7, 2012 – Windsor Health Group and MedHOK, one of the healthcare industry’s fastest growing software companies, announced today that Windsor’s Medicare Advantage business, Windsor Health Plan, Inc., will deploy MedHOK’s single platform for care, quality and compliance to proactively close care gaps, enhance care management, improve Star scores and ensure compliance.  In doing so, Windsor is positioning itself to succeed in the rapidly changing healthcare environment that is emphasizing care and quality outcomes.

MedHOK offers fully NCQA certified software for HEDIS®, Pay for Performance and Disease Management performance measures. The company has more than 18 million lives in production and is on track to double this number within the year.

Nashville-based Windsor Health Plan, Inc., which provides Medicare Advantage and standalone Part D prescription drug plans for more than 157,000 Americans, will use MedHOK’s platform  to bolster care management quality for its members across 28 states:

  • MedHOK’s 360Member™ solution to increase its commitment to member-focused care
  • Utilization Management
  • Pharmacy Coverage Determinations and Redeterminations
  • Case and Disease Management
  • Predictive modeling and stratification
  • Part C and Part D Star improvement, quality and care gap closure
  • Pay for Performance
  • Grievances
  • Appeals
  • CMS Complaint Tracking Modules (CTMs) and general complaints
  • Independent Review Entity and external appeals
  • Correspondence/fulfillment, dashboard, reporting and audit functionality

“Windsor Health Plan and our employees have as our highest priority to ensure that our members receive the best quality of care available in the markets we serve.  Our strategy is to continue to invest in comprehensive clinical and member management systems like MedHOK that help improve quality and virtually every facet of the user experience for both our members and providers alike. We know that future success depends on constantly driving quality improvement and providing excellent service that our members expect and deserve,” said Michael A. Muchnicki, Chief Executive Officer of Windsor Health Group.

MedHOK’s integrated care management, quality and compliance platform facilitates improved clinical outcomes and care coordination while enhancing quality measures, compliance and financial performance. It accomplishes this by:

  • Providing real-time access to Star, HEDIS, pay-for-performance (P4P), and proprietary quality and performance measures, helping plans and providers to accurately monitor in real-time the data they need to achieve and maintain high quality ratings.
  • Triggering interventions when care gaps are identified, in particular for patients with multiple co-morbidities and chronic conditions.
  • Utilizing predictive analytics models to generate profiles based on clinical, quality and financial data for member, provider and local populations.
  • Calculating risk scores for every member, enabling timely predictions of those at the highest risk for more accurate forecasting of care costs and utilization.
  • Continuously monitoring for and addressing regulatory changes from CMS and state Medicaid agencies, ensuring clients stay ahead of the compliance curve.

“With the passage of health reform, all lines of business will see revenue directly tied to care, quality and compliance outcomes.  Health plans will need to deploy the right technologies that enable continuous monitoring of key care and performance measures,” said Anil Kottoor, president and CEO, MedHOK. “MedHOK’s single platform for care, quality and compliance is built for health plans and other entities seeking to succeed in this new rigorous, results-oriented environment.  We are proud to partner with Windsor to meet their future needs.”

About MedHOK

Tampa, Fla.-based MedHOK has more than 18 million lives in production and expects to double that number in 2012, making it one of the healthcare industry’s fastest-growing software companies. It offers a cloud-based integrated software platform for care management, quality and compliance that enables physicians, ACOs, PCMHs, payers and TPAs to manage and measure care against national quality standards for optimal outcomes. Its innovative modular software helps healthcare organizations meet quality, care and compliance objectives across business lines by facilitating real-time information sharing with all stakeholders to address disease management and care coordination, clinical quality and utilization review, and quality and financial measures. ICD-10 compliant, HIE-ready and securely accessible on any device, the MedHOK platform is user-friendly, rapidly deployed and easily configurable for a low total cost of ownership and rapid return on investment. It holds 2012 HEDIS®, Pay for Performance and Disease Management performance measures certification.

About Windsor

Windsor Health GroupSM refers to Windsor Health Group, Inc., an insurance holding company and its operating subsidiaries, which include Windsor Health Plans, Inc. (WHP), and Sterling Life Insurance Company (SLIC). WHG, through WHP and SLIC, serves more than 230,000 Americans with a variety of insurance offerings for the senior population. WHG is a subsidiary of Munich Health North America, Inc., which is a subsidiary of Munich Reinsurance Company (Munich Re), one of the world’s leading reinsurers.

August 22, 2012 I Written By

Wolters Kluwer Health’s Sentri7® Patient Surveillance Software Receives High Marks in Two Recent KLAS Reports

Bellevue, Wash. — Aug. 21, 2012— Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that a recent KLAS report found that 92% of customers who had purchased its Sentri7® Infection Prevention* patient surveillance technology would buy again. Infection Control Systems 2012: Breaking Barriers and Getting Value also reported that Sentri7 Infection Prevention had earned an overall performance score of 88.5% and rated well in all functional areas with no gaps in satisfaction scores.

Another KLAS report, Clinical Decision Support 2011: Understanding the Impact, rated Pharmacy OneSource Sentri7 as having the highest impact on quality outcomes when compared to other types of clinical decision support tools currently being used in the healthcare market. The product achieved a positive impact score of greater than 80%.

Sentri7® is a web-based platform that aggregates, monitors and delivers patient data in real-time from disparate hospital information systems to assist providers in delivering optimum patient care, reducing drug costs, and improving outcomes. The smart logic contained within the electronic surveillance system allows for a rules-based approach to infection prevention that targets specific conditions to support hospital quality initiatives.

For the Infection Control Systems report, KLAS, an independent healthcare IT vendor research firm that recognizes healthcare vendors for their leadership in working with customers to ensure satisfaction, spoke with 119 providers managing infection control processes on paper and 202 currently using an infection control system. The research specifically focused on system performance for National Healthcare Safety Network (NHSN) reporting, analytics, interfacing and ability to enhance the efforts of infection prevention professionals.

For the Clinical Decision Support report, KLAS interviewed 404 providers to rate the performance of a variety of decision support tools including care plans, diagnostic decision support tools, disease reference tools, drug databases, drug reference tools, order sets and surveillance tools. The impact was measured by asking providers to rate the influence the various tools had on clinical decisions and standardizing care.

“The stakes are high for patient safety. Using electronic surveillance technology is a critical strategy for hospitals seeking to eliminate healthcare-associated infections and maximize reimbursement in the era of value-based purchasing,” said Tim Gibbons, Vice President & General Manager, Pharmacy OneSource, Wolters Kluwer Health Clinical Solutions. “We are pleased to have received these high scores from customers and believe it demonstrates our commitment to delivering technology to help them identify potential HAI earlier and provide treatment options to reduce overall healthcare cost.  This truly shapes the future of healthcare.”

About Pharmacy OneSource

Pharmacy OneSource® is healthcare’s #1 Software-as-a-Service (SaaS) provider. Our more than 100 innovative team members provide best-in-class, SaaS solutions to current and future challenges within health-systems worldwide. Our SaaS solutions contribute to swift and safe healthcare through earlier, easier and better access to data. More than 1,300 healthcare organizations worldwide utilize our HIPAA compliant web-based services.

Pharmacy OneSource is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and be counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Founded in 1996, KLAS staff and advisory board average 25 years of healthcare information technology experience. For more information, go to www.KLASresearch.com, email marketing@KLASresearch.com, or call 1-800-920-4109 to speak with a KLAS representative. Follow KLAS on Twitter at www.twitter.com/KLASresearch.

I Written By

Simply Healthcare Selects MedHOK to Enhance Quality Improvement Initiatives

TAMPA, Fla. – Feb. 28, 2012 – MedHOK, one of the healthcare industry’s fastest growing companies providing cloud-based software, announced today that Simply Healthcare will deploy its integrated care management, quality and compliance platform to proactively enhance its quality improvement initiatives. In doing so, Simply Healthcare is well positioned to respond to Centers for Medicare & Medicaid Services (CMS) and the Florida Agency for Health Care Administration (AHCA) efforts to enhance quality outcomes and reduce costs. MedHOK, which offers fully NCQA certified software for HEDIS®, has more than 15 million live in production and is on track to reach 30 million within the year, making it one of the healthcare industry’s leading software companies.

Simply Healthcare is a Coral Gables, Fla.-based HMO that serves Florida’s Medicaid and Healthy Kids populations and Medicare Advantage members. It will leverage the MedHOK platform for annual HEDIS filings, as well as to identify and remediate any care gaps and improve outcomes going forward.

“We appreciate the expertise MedHOK brings to the table and their collaborative approach to achieving our goals,” said Dwight Pattison, director of quality management, Simply Healthcare.

MedHOK’s integrated care management, quality and compliance platform facilitates improved clinical outcomes and care coordination while enhancing quality measures, compliance and financial performance. It accomplishes this by:

  • Providing real-time access to Star, HEDIS, pay-for-performance (P4P), and proprietary quality and performance measures, helping providers accurately monitor in real-time the data they need to achieve and maintain high quality ratings
  • Triggering interventions when care gaps are identified, in particular for patients with multiple comorbidities and chronic conditions
  • Utilizing predictive analytics models to generate profiles based on clinical, quality and financial data for member, provider and local populations
  • Calculating risk scores for every member, enabling timely predictions of those at the highest risk for more accurate forecasting of care costs and utilization
  • Continuously monitoring for and addressing regulatory changes from CMS and state Medicaid agencies, ensuring clients stay ahead of the compliance curve

“To thrive into today’s healthcare environment, health plans must be committed to improving quality and reducing costs,” said Anil Kottoor, president and CEO, MedHOK. “By leveraging the power of our integrated care, quality and compliance platform, they can eliminate the year-end HEDIS fire drills through continuous performance monitoring and streamlined workflows that mitigate care gaps.”

About MedHOK

Tampa, Fla.-based MedHOK has more than 15 million lives in production and expects to double that number in 2012, making it one of the healthcare industry’s fastest-growing software companies. It offers a cloud-based integrated software platform for care management, quality and compliance that enables physicians, ACOs, PCMHs, payers and TPAs to manage and measure care against national quality standards for optimal outcomes. Its innovative modular software helps healthcare organizations meet quality, care and compliance objectives across business lines by facilitating real-time information sharing with all stakeholders to address disease management and care coordination, clinical quality and utilization review, and quality and financial measures. ICD-10 compliant, HIE-ready and securely accessible on any device, the MedHOK platform is user-friendly, rapidly deployed and easily configurable for a low total cost of ownership and rapid return on investment. The company’s 360Measures holds full 2012 HEDIS® certification.

March 30, 2012 I Written By

EBSCO Publishing and Isabel Healthcare to Provide Integrated Access to Content in Isabel and DynaMed™ – #HIMSS12

A new agreement between EBSCO Publishing and Isabel Healthcare allows mutual customers to link from the Isabel diagnosis tool and the evidence-based point-of-care tool DynaMed. The agreement brings the evidence-based content from DynaMed into the diagnostic process and allows users easier access regardless of whether a search begins in Isabel or DynaMed.

DynaMed is a clinical reference tool created by physicians for physicians and other health care professionals for use at the point-of-care. The daily updates in DynaMed have led to DynaMed being recognized as the most current point-of-care reference in The British Medical Journal (BMJ 2011 Sep 23) and helped DynaMed rate higher than other disease reference tools in the latest KLAS report on Clinical Decision Support (Clinical Decision Support 2011: Understanding the Impact, 2011. © 2011 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com).

You can learn more about DynaMed, the Isabel agreement and the importance of evidence-based medicine in the clinical workflow by visiting the EBSCO Publishing booth (#819) at HIMSS 2012.

Agreement Provides Linking Between Isabel’s Diagnosis Decision Support Tool and the Evidence-Based Clinical Decision Support Content from DynaMed

IPSWICH, Mass. — February 21, 2012 — Institutions using the clinical decision support resources Isabel and DynaMed  will benefit from tighter integration of the two tools. A new agreement between Isabel Healthcare and EBSCO Publishing allows direct linking between the Isabel diagnosis tool and the evidence-based point-of-care tool DynaMed, allowing mutual customers to link from one resource to the other. The agreement brings the evidence-based content from DynaMed into the diagnostic process and allows users easier access regardless of whether a search begins in Isabel or DynaMed.

Isabel Healthcare provides a web-based application called Isabel, the industry leading diagnosis decision support system designed to provide essential diagnosis and treatment information at the point of need. For a given set of signs and symptoms, Isabel presents the clinician with a list of likely diagnoses to consider, and each diagnosis is linked to knowledge to help with further investigation, potential testing and treatment. The Isabel system has been extensively validated and is currently being used by leading healthcare systems across North America improving efficiency in decision making.

“We are excited about the tighter integration between DynaMed and Isabel and the decision making efficiencies associated with easy access to information at the point-of-need,” stated Don Bauman, CEO of Isabel Healthcare. “Improving decision making efficiency affords clinicians with more patient-facing time, improves time to diagnosis and treatment, and lowers costs.”

DynaMed is a clinical reference tool created by physicians for physicians and other health care professionals for use at the point-of-care. With clinically-organized summaries for more than 3,200 topics, DynaMed provides the latest content and resources with validity, relevance and convenience, making DynaMed an indispensable resource for answering most clinical questions during practice.

Updated daily, DynaMed editors monitor the content of over 500 medical journals on a daily basis. Each article is evaluated for clinical relevance and scientific validity. The new evidence is then integrated with existing content, and overall conclusions are changed as appropriate, representing a synthesis of the best available evidence. Through this process of Systematic Literature Surveillance, the best available evidence determines the content of DynaMed.

About Isabel Healthcare

Isabel Healthcare Inc. was founded in 2000 by Jason Maude and is named after Maude’s daughter who almost died after a potentially fatal illness was not recognized. For over 10 years, Isabel Healthcare has provided the Isabel diagnosis decision support system to hospitals, physician practices and individual physicians and gained peer reviewed validation and unmatched experience. Today, Isabel is the only diagnosis decision support system fully integrated with EMR and is used by thousands of physicians, nurse practitioners, physician assistants and students world-wide, providing diagnostic support and education by broadening their differential diagnostic considerations. Connect with us at info(at)isabelhealthcare(dot)com, 734-332-0612 or http://www.isabelhealthcare.com or http://www.twitter.com/isabelhealth to learn more.

About EBSCO Publishing

EBSCO Publishing is the world’s premier database aggregator, offering a suite of more than 350 full-text and secondary research databases. Through a library of tens of thousands of full-text journals, magazines, books, monographs, reports and various other publication types from renowned publishers, EBSCO serves the content needs of all medical professionals (doctors, nurses, medical librarians, social workers, hospital administrators, etc.). The company’s product lines include proprietary databases such as CINAHL®, DynaMed, Nursing Reference Center, Patient Education Reference Center, Rehabilitation Reference Center, Rehabilitation & Sports Medicine Source and SocINDEX as well as dozens of leading licensed databases such as MEDLINE®, PsycARTICLES® and PsycINFO®. Databases are powered by EBSCOhost®, the most-used for-fee electronic resource in libraries around the world. For more information, visit the EBSCO Publishing Web site at: www.ebscohost.com, or contact: information@ebscohost.com.

February 22, 2012 I Written By

Children’s Hospital & Medical Center and Loma Linda University Children’s Hospital Select Isabel Healthcare – #HIMSS12

Diagnosis decision support tool helps physicians determine correct diagnosis the first time; enhances point-of-care diagnostic skills of residents and medical students

LAS VEGAS-HIMSS Annual Conference-Feb. 20, 2012-Isabel Healthcare today announced that Children’s Hospital & Medical Center, Omaha, Neb., and Loma Linda University Children’s Hospital(LLUCH), Loma Linda, Calif., have selected Isabel, its diagnosis decision support and clinical knowledge system to assist their combined 950 physicians identify a patient’s diagnosis accurately the first time. The two facilities will further employ the Isabel web application to instruct, train and improve the diagnostic skills of residents and medical students at the point of care.

Isabel Healthcare will demonstrate its solution at booth #13247 at the annual Healthcare Information and Management Systems Society’s (HIMSS) Conference. The event is this week at the Venetian Sands Expo Center in Las Vegas.

“We chose Isabel because there is no other decision support solution like it on the market,” said George Reynolds, M.D., MMM, vice president, chief medical informatics officer and chief information officer at the 145-bed Children’s Hospital & Medical Center. “When our physicians work unusual or complex cases, they can enter the symptoms at the point of care into Isabel, and the solution will generate potential diagnoses. This tool empowers our 600 doctors in making the right decisions and arrive at the right diagnosis as quickly and efficiently as possible.”

Children’s (Omaha, Neb.) will integrate Isabel with an ambulatory EMR and its new inpatient electronic health record (EHR).

“Like every other EHR, our electronic records solution is bundled with traditional clinical decision support,” continued Reynolds, a pediatric intensivist. “However, that kind of decision support software differs significantly from Isabel’s because it is more closely aligned with medication prescribing. It tells experienced clinicians how to treat a diagnosis that they have already determined. Isabel, instead, helps them identify the diagnosis. The tool broadens our decision support portfolio and greatly expands the quality of care we deliver to infants, children and young adults.”

In addition to decision support, Children’s will use Isabel as a resource to teach its more than 150 residents and medical students from the University of Nebraska Medical Center College of Medicine and Creighton University School of Medicine.

“Isabel is a remarkably potent teaching tool,” Reynolds said. “Not only does it provide very specialized advice to practitioners who are very experienced, the solution serves as a general educational platform for residents just launching their careers and medical students.”

Richard Chinnock, M.D., chair of the Department of Pediatrics at Loma Linda University School of Medicine and physician-in-chief at the 277-bed LLUCH, which renewed its contract with Isabel, agreed.

“At LLUCH, we have several physicians who have written the textbook in their specialty,” Chinnock explained. “They don’t need Isabel to figure out complicated diagnoses; however, the residents who work with them and who admit and evaluate patients want to know what those experts are thinking. Isabel helps our house staff and medical students hone their clinical and diagnostic skills. It’s a tremendous teaching aid.”

“We are honored to partner with Children’s Hospital and Loma Linda to support their shared mission to achieve clinical excellence and train the next generation of practicing physicians,” said Don Bauman, Isabel Healthcare’s chief executive officer. “Finding time to diagnose early and accurately in our knowledge-intensive industry is a huge challenge and if performed incorrectly can waste resources and lead to potentially life threatening and costly errors. Our knowledge management tool helps doctors reach a more informed judgment in a matter of seconds.This advanced intelligence can lead to more appropriate test ordering and treatment planning.”

About Children’s Hospital & Medical Center

Proudly serving children since 1948, Children’s Hospital & Medical Center is recognized as a 2011-12 Best Children’s Hospital by U.S. News & World Repot in cardiology and heart surgery, and orthopedics. It is the only full-service, pediatric health care center in Nebraska providing expertise in more than 30 pediatric specialty services to children across a five-state region and beyond. Located in Omaha, the 145-bed, non-profit hospital houses the only dedicated pediatric emergency department in the region and offers 24-hour, in-house services by pediatric critical care specialists.

About Loma Linda University Children’s Hospital

Loma Linda University Children’s Hospital (LLUCH) includes services for all pediatric patients and for obstetrics. It is internationally recognized for its pioneering pediatric heart transplant program and for having the first clinically dedicated proton beam treatment center in the world. LLUCH offers a full spectrum of services, including heart, kidney and bone marrow transplant. It hosts a level I pediatric trauma center – one of only three in the state. An 84-bed NICU, 25-bed PIC and 14-bed Cardiac ICU bring cutting edge therapies to a 4-county area of California comprising approximately 25% of the land mass of the state. It is the major teaching hospital for pediatric training for 82 pediatric and med/peds residents and for 170 medical students of Loma Linda University School of Medicine.

About Isabel Healthcare

Isabel Healthcare Inc. was founded in 2000 by Jason Maude and is named after Maude’s daughter who almost died after a potentially fatal illness was not recognized. For over 10 years, Isabel Healthcare has provided the Isabel diagnosis decision support system to hospitals, physician practices and individual physicians and gained peer reviewed validation and unmatched experience. Today, Isabel is the only diagnosis decision support system fully integrated with EMR and is used by thousands of physicians, nurse practitioners, physician assistants and students world-wide, providing diagnostic support and education by broadening their differential diagnostic considerations. Connect with us at info@isabelhealthcare.com, 734-332-0612 or Isabelhealthcare.com or info.isabelhealthcare.com/blog to learn more.

February 20, 2012 I Written By